1. Filarial thioredoxin reductase exerts anti-inflammatory effects upon lipopolysaccharide induced inflammation in macrophages.
- Author
-
Joardar N, Bhattacharya R, Halder S, Sen A, Biswas SR, Jana K, and Babu SPS
- Subjects
- Animals, Cell Line, Down-Regulation drug effects, Helminth Proteins metabolism, Inflammation chemically induced, Lipopolysaccharides pharmacology, Mice, NF-kappa B metabolism, Protein Conformation, alpha-Helical drug effects, Protein Conformation, beta-Strand drug effects, RAW 264.7 Cells, Setaria Nematode drug effects, Toll-Like Receptor 4 metabolism, Anti-Inflammatory Agents metabolism, Anti-Inflammatory Agents pharmacology, Inflammation drug therapy, Inflammation metabolism, Macrophages metabolism, Thioredoxin-Disulfide Reductase metabolism, Thioredoxin-Disulfide Reductase pharmacology
- Abstract
Lymphatic filariasis and its associated health hazards have taken enormous tolls especially in the tropical and sub-tropical countries round the globe. Our present work contemplates the immunomodulatory role of filarial Thioredoxin reductase (TrxR) for the survival of the parasite inside the human host. For this, the protein TrxR was purified from the filarial parasite Setaria cervi and further substantiated through specific anti-TrxR antibody raised in mice. Both commercially available anti-TrxR antibody and laboratory raised antibody produced a single band with a molecular mass of ~80 kDa on western blot. The protein is optimally active at pH 7.0 and at temperature 37 °C. This protein contains both alpha helix and beta pleated sheet with selenocysteine at its active site. The Km was found to be 2.75 ± 0.49 mM. TrxR was found to downregulate lipopolysaccharide (LPS)-induced inflammation in macrophages due to inhibition of TLR4-NF-κB pathway. The result was further supported by the downregulation of inflammasome pathway and activation of alternatively activated macrophages upon TrxR treatment. Hence this study projects insights into the importance of filarial TrxR in host-parasite interface as well as it illustrates novel therapeutic strategy towards anti-filarial drug development., (Copyright © 2021 Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF